Femasys Inc. (FEMY) |
|
1.085 -0.105 (-8.82%)
|
03-31 15:52 |
|
Open: |
1.04 |
Pre. Close: |
1.19 |
|
High:
|
1.1 |
Low:
|
1.04 |
|
Volume:
|
12,127 |
Market Cap:
|
13(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:18:39 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.41  One year: 1.68 |
| Support: |
Support1: 0.83 Support2: 0.69 |
| Resistance: |
Resistance1: 1.21 Resistance2: 1.44 |
| Pivot: |
1.12 |
| Moving Average: |
MA(5): 1.16 MA(20): 1.13
MA(100): 1.14 MA(250): 1.46 |
| MACD: |
MACD(12,26): 0 Signal(9): 0  |
| Stochastic oscillator: |
%K(14,3): 71.7 %D(3): 69.9 |
| RSI: |
RSI(14): 45.8 |
| 52-week: |
High: 2.97 Low: 0.56 |
| Average Vol(K): |
3-Month: 15 (K) 10-Days: 15 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ FEMY ] has closed above bottom band by 42.6%. Bollinger Bands are 45.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.25 - 1.26 |
1.26 - 1.26 |
|
Low:
|
1.09 - 1.1 |
1.1 - 1.11 |
|
Close:
|
1.14 - 1.15 |
1.15 - 1.16 |
|
Company Description |
|
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. |
Headline News |
Fri, 31 Mar 2023
Chardan Capital Maintains Buy Rating for Femasys: Here's What ... - Benzinga
Fri, 31 Mar 2023
Our Exclusive Articles - Benzinga
Thu, 30 Mar 2023
Femasys Inc. Announces Financial Results for the Year Ended ... - GlobeNewswire
Thu, 16 Mar 2023
Why Titan Machinery Shares Are Trading Lower By Around 18 ... - Investing.com UK
Thu, 09 Mar 2023
Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023 - Yahoo Finance
Mon, 19 Dec 2022
Femasys Inc. Announces Commercial Availability of its FemCath ... - GlobeNewswire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
12 (M) |
| Shares Float |
9 (M) |
|
% Held by Insiders
|
19 (%) |
|
% Held by Institutions
|
8.5 (%) |
|
Shares Short
|
7 (K) |
|
Shares Short P.Month
|
14 (K) |
Stock Financials |
|
EPS
|
-0.88 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.51 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-893.6 |
|
Return on Assets (ttm)
|
-26.8 |
|
Return on Equity (ttm)
|
-46.6 |
|
Qtrly Rev. Growth
|
28.8 |
|
Gross Profit (p.s.)
|
0.06 |
|
Sales Per Share
|
0.1 |
|
EBITDA (p.s.)
|
-0.88 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-10 (M) |
|
Levered Free Cash Flow
|
-6 (M) |
Stock Valuations |
|
PE Ratio
|
-1.24 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0.71 |
|
Price to Sales
|
10.46 |
|
Price to Cash Flow
|
-1.28 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
